Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (91)

2024

  1. Baroreflex activation therapy in patients with heart failure and reduced ejection fraction

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 342-344

  2. Cardiovascular surgery and cardiology, current status of two sister specialties in Spain: the CARDIOXCARDIO study

    Revista Espanola de Cardiologia

  3. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

    British Journal of Surgery, Vol. 111, Núm. 3

  4. Circadian rhythm of heart rate in patients with heart failure. Response

    Revista Espanola de Cardiologia

  5. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure

    ESC Heart Failure, Vol. 11, Núm. 3, pp. 1767-1776

  6. Evolution of the impact of the COVID-19 pandemic on heart transplant recipients: Decreasing risk, improving perspective

    Transplant Infectious Disease, Vol. 26, Núm. 2

  7. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301

  8. Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78

2023

  1. Conduction system pacing and atrioventricular node ablation in heart failure: The PACE-FIB study design

    ESC Heart Failure, Vol. 10, Núm. 6, pp. 3700-3709

  2. De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  3. Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881

  4. In-hospital outcomes following percutaneous versus surgical intervention in the treatment of aortic stenosis and concomitant coronary artery disease

    Revista Espanola de Cardiologia, Vol. 76, Núm. 8, pp. 600-608

  5. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction

    Clinical Research in Cardiology

  6. Intermittent hypoxic-hyperoxic conditioning for heart failure rehabilitation

    REC: CardioClinics, Vol. 58, Núm. 2, pp. 79-87

  7. Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204

  8. Opinion on the 2021 ESC guidelines on heart failure: a cross-sectional survey of 387 doctors

    REC: CardioClinics, Vol. 58, Núm. 1, pp. 7-15

  9. Selection of the best of 2022 in heart failure

    REC: CardioClinics, Vol. 58, pp. S42-S48

  10. Takotsubo Syndrome, Stressful Triggers, and Risk of Recurrence

    American Journal of Cardiology, Vol. 205, pp. 58-62

  11. Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  12. Twenty-four hour ambulatory blood pressure monitoring in patients with stable heart failure. Prevalence and associated factors

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 852-861